The significant genomic differences between the PA and PDX tumors observed in P06 may be due to the imbalanced growth of primary tumor cells or the loss of mutations because more than 90% of mutations derived from PA and TP53 mutations were lost in the PDX model. This evidence concerns the gene TP53 and neoplasm.